Tactile Systems Technology

General Information

We are a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home. We focus on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. We possess a unique, scalable platform to deliver at-home healthcare solutions throughout the United States. This evolving care delivery model is recognized by policy-makers and payers as a key for controlling rising healthcare expenditures. Our initial area of therapeutic focus is vascular disease, with a goal of advancing the standard of care in treating lymphedema and chronic venous insufficiency. Our proprietary Flexitouch System is an at-home solution for lymphedema patients.

Employees: 275
Founded: 1995
Contact Information
Address 1331 Tyler Street NE, Suite 200, Minneapolis, MN 55413, US
Phone Number (612) 355-5100
Web Address http://www.tactilemedical.com
View Prospectus: Tactile Systems Technology
Financial Information
Market Cap $166.5mil
Revenues $66.5 mil (last 12 months)
Net Income $-0.6 mil (last 12 months)
IPO Profile
Symbol TCMD
Exchange NASDAQ
Shares (millions): 4.0
Price range $10.00 - $10.00
Est. $ Volume $40.1 mil
Manager / Joint Managers Piper Jaffray/ William Blair/ Canaccord Genuity
CO-Managers BTIG
Expected To Trade: 7/28/2016
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change